Spot on Makwa - I agree. It really depends on the premium (if any with these market conditions!) the company can extract to validate if the convertible loan was ideal.
I guess for consolation is the company has approximately $12.5m cash (as at 30 Sept) so there's no immediate need to raise capital.
- Forums
- ASX - By Stock
- SRQ
- Ann: YTC moves to 100% of Doradilla Project
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online